Efficacy and safety of combined androgen blockade with antiandrogen for advanced prostate cancer

BACKGROUND: Combined androgen blockade (cab) is a promising treatment modality for prostate cancer (pca). In the present meta-analysis, we compared the efficacy and safety of first-line cab using an antiandrogen (aa) with castration monotherapy in patients with advanced pca. METHODS: PubMed, embase,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Curr Oncol
Hlavní autoři: Yang, Y., Chen, R., Sun, T., Zhao, L., Liu, F., Ren, S., Wang, H., Lu, X., Gao, X., Xu, C., Sun, Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380654/
https://ncbi.nlm.nih.gov/pubmed/30853808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4203
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky